Edwards Lifesciences
In François Rochon's portfolio · Giverny Capital
Ticker EW
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Giverny Capital 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q1 2025 | Sell | 0 | |
| Q4 2024 | Reduce 100% | 257 | 0.0% |
| Q3 2024 | No change | 446,288 | 1.1% |
| Q2 2024 | No change | 446,016 | 1.7% |
| Q1 2024 | Add 1% | 445,718 | 1.7% |
| Q4 2023 | No change | 440,906 | 1.6% |
| Q3 2023 | No change | 440,602 | 1.7% |
| Q2 2023 | Add 6% | 439,896 | 2.2% |
| Q1 2023 | Reduce 3% | 414,975 | 2.1% |
| Q4 2022 | Reduce 1% | 426,173 | 2.0% |
| Q3 2022 | Add 3% | 430,196 | 2.4% |
| Q2 2022 | Add 3% | 416,882 | 2.6% |
| Q1 2022 | No change | 405,091 | 2.7% |
| Q4 2021 | Reduce 50% | 405,762 | 2.8% |
| Q3 2021 | Add 98% | 804,300 | 2.7% |
| Q2 2021 | Add 4% | 405,529 | 2.6% |
| Q1 2021 | Add 1% | 390,140 | 2.2% |
| Q4 2020 | Add 4% | 387,814 | 2.7% |
| Q3 2020 | No change | 373,422 | 2.7% |
| Q2 2020 | Add 5%after split | 372,627 | 2.6% |
| Q1 2020 | Reduce 8% | 118,426 | 2.8% |
| Q4 2019 | Add 1% | 128,515 | 2.7% |
| Q3 2019 | No change | 127,233 | 2.8% |
| Q2 2019 | Add 2% | 126,990 | 2.4% |
| Q1 2019 | Add 1% | 123,923 | 2.7% |
| Q4 2018 | Reduce 32% | 122,178 | 2.5% |
| Q3 2018 | Add 5% | 180,690 | 3.6% |
| Q2 2018 | Add 1% | 172,508 | 3.3% |
| Q1 2018 | Add 6% | 171,166 | 3.2% |
| Q4 2017 | Buy | 161,571 | 2.5% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.